http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1171276-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7eb80161b9faff941939c3ed3754cad
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 1998-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e963ba1c639af0e4385be13d676e95e5
publicationDate 1999-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H1171276-A
titleOfInvention Breast cancer suppressants containing melatonin and combinations for suppressing breast cancer
abstract (57) [Summary] [PROBLEMS] To obtain a substance capable of inhibiting the induction of breast cancer. SOLUTION: The induction of breast cancer is prevented by administering a breast cancer inhibitor containing melatonin or a melatonin analog to a human woman every day for a certain period of time. It may be administered in combination with a progestogen and / or an estrogen. The daily dose of melatonin for women weighing 70 kg is 2 mg to 1000 mg, the dose of progestogen is 7.5 μg to 2500 μg, and the dose of estrogen is 2 μg to 100 μg. It is administered orally, by intravenous injection or subcutaneous implantation in a physiologically suitable carrier.
priorityDate 1987-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9929903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409954527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13872
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3001028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6432547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415852843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426106036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591920
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426359611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426152476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408403335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14626804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493599
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108710621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9324

Total number of triples: 89.